IMMUNIC, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)

Item 2.02. Results of Operations and Financial Condition

On August 2, 2020, Immunic, Inc. (the "Company") issued a press release announcing its financial results for the quarter ended June 30, 2020. The full text of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference.

Item 7.01. Regulation FD Disclosure

On August 2, 2020 and August 3, 2020, respectively, the Company issued a press release and presented a business update regarding positive top-line data from its phase 2 EMPhASIS trial of IMU-838 in patients with relapsing-remitting multiple sclerosis. The press release and presentation are attached as Exhibits 99.1 and 99.2 to this Current Report on Form 8-K and are incorporated herein by reference.

The information in Item 2.02 and Item 7.01 of this Current Report on Form 8-K and Exhibits 99.1 and 99.2 attached hereto, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Items 2.02 and 7.01 of this Current Report and Exhibits 99.1 and 99.2 attached hereto shall not be incorporated by reference into any registration statement or other document filed with the Securities and Exchange Commission, whether filed before or after the date hereof regardless of any general incorporation language in any such filing, unless the registrant expressly sets forth in such filing that such information is to be considered "filed" or incorporated by reference therein.

Item 8.01. Other Events

On August 3, 2020, the Company posted an updated corporate presentation on its website. A copy of the presentation is filed herewith as Exhibit 99.3 and is incorporated herein by reference. The updated presentation filed herewith supersedes any corporate presentations previously filed by the Company.

Item 9.01. Financial Statements and Exhibits

Exhibit   Description

 99.1       Press Release, dated August 2, 2020.
 99.2       Presentation, dated August 3, 2020.
 99.3     Presentation, dated August 3, 2020.

© Edgar Online, source Glimpses